W. Thomas Mitchell is Director at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 4 open-market trades across 2 companies since 2006, most recently 2015-06-23.
CIK 0001214352
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $45K since 2006, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL · 10b5-1 | 2015-06-23 | 2015-06-24 | $49.35 | $740K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-01-13 | 2015-01-15 | $30.07 | $1.4M | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2015-01-02 | 2015-01-06 | $22.79 | $182K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-12-10 | 2014-12-12 | $21.90 | $153K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2014-10-01 | 2014-10-03 | $15.50 | $20K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2013-08-06 | 2013-08-07 | $14.70 | $23K | -24.3% | -5.3% | -5.3% |
| NBIX | SELL · 10b5-1 | 2012-12-05 | 2012-12-07 | $7.41 | $7K | -24.3% | -5.3% | -5.3% |
| NBIX | BUY | 2009-11-05 | 2009-11-06 | $2.17 | $2K | -24.3% | -5.3% | -5.3% |
| DJO | BUY | 2006-12-14 | 2006-12-18 | $43.18 | $43K | N/A | N/A | N/A |
| DJO | SELL | 2006-11-20 | 2006-11-27 | $45.07 | $451K | N/A | N/A | N/A |
| DJO | SELL | 2006-05-17 | 2007-03-26 | $42.00 | $420K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.